LOYD v. ABBOTT LABORATORIES et al

New Jersey District Court
Judge:Claire C Cecchi
Referred: Mark Falk
Case #: 2:19-cv-08400
Nature of Suit367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause28:1332 Diversity-Product Liability
Case Filed:Mar 12, 2019
Terminated:Jun 10, 2022
Last checked: Sunday Sep 08, 2019 5:54 AM EDT
Defendant
THE PROCTER & GAMBLE MANUFACTURING COMPANY
Defendant
ABBOTT LABORATORIES
Defendant
ASTRAZENECA LP
Defendant
ASTRAZENECA PHARMACEUTICALS LP
Defendant
THE PROCTER & GAMBLE COMPANY
Defendant
MERCK & CO. INC. D/B/A MERCK, SHARP & DOHME CORPORATION
Defendant
NOVARTIS CONSUMER HEALTH, INC.
Defendant
NOVARTIS CORPORATION
Defendant
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Defendant
NOVARTIS PHARMACEUTICAL CORPORATION
Defendant
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Defendant
TAKEDA DEVELOPMENT CENTER AMERICAS, INC. F/K/A TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.
Defendant
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Defendant
TAKEDA PHARMACEUTICALS AMERICA INC.
Defendant
TAKEDA PHARMACEUTICALS USA, INC.
In Re
PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II)
Plaintiff
MATTHEW LOYD
Represented By
LUKE FITZGERALD CALLAHAN
Counsel Not Admitted To Usdc-Nj Bar
contact info


Docket last updated: 09/22/2026 11:59 PM EDT
Thursday, May 22, 2025
14 14 30+ pgs order Order Thu 05/22 9:23 AM
MDL ORDER CONVERTING DISMISSALS WITHOUT PREJUDICE AGAINST ASTRAZENECA and MERCK DEFENDANTS TO DISMISSALS WITH PREJUDICE FOR FAILURE TO COMPLY WITH CMO 127. Signed by Judge Claire C. Cecchi on 5/20/2025. (jl, )
Related: [-]
Thursday, March 27, 2025
13 13 30+ pgs order Order Thu 03/27 6:23 PM
Order re Dismissals Without Prejudice Transitioning to Dismissals With Prejudice re: AstraZeneca & Merck Defendants filed in the Master under CMO127 [DE#1056]. Signed by Judge Claire C. Cecchi on 3/27/2025. (jl, )
Related: [-]
Friday, June 10, 2022
12 12 notice Notice of Voluntary Dismissal (aty) Fri 06/10 11:56 AM
NOTICE of Voluntary Dismissal by MATTHEW LOYD (TOOMEY, JOAN)
Related: [-]
order Order of Dismissal Fri 06/10 11:59 AM
TEXT ORDER OF DISMISSAL. Signed by Judge Claire C. Cecchi on 6/10/2022. (krg, )
Related: [-]
Friday, January 21, 2022
10 10 misc Stipulation of Dismissal (aty) Fri 01/21 1:11 PM
STIPULATION of Dismissal Joint/Without Prejudice by NOVARTIS CONSUMER HEALTH, INC.. (MCCONNELL, STEPHEN)
Related: [-]
9 9 notice Notice of Appearance Fri 01/21 11:19 AM
NOTICE of Appearance by JOAN D. TOOMEY on behalf of MATTHEW LOYD (TOOMEY, JOAN)
Related: [-]
order Stipulation and Order ~Util - Add and Terminate Parties Fri 01/21 3:37 PM
STIPULATION and TEXT ORDER of DISMISSAL as to NAMED DEFENDANTS ONLY. (NOVARTIS CONSUMER HEALTH, INC. terminated). Signed by Judge Claire C. Cecchi on 1/21/2022. (krg, )
Related: [-]
Monday, January 10, 2022
utility Case Assigned/Reassigned Mon 01/10 8:35 AM
Case Reassigned to Magistrate Judge Leda D. Wettre. Magistrate Judge Mark Falk no longer assigned to the case. (dc, )
Related: [-]
Monday, December 06, 2021
7 7 13 pgs order Order Mon 12/06 11:23 AM
ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days of the date of this Order to (1) establish that service was effected on the identified GSK Defendants3 as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss the identified GSK Defendants, or (3) show cause why the identified GSK Defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 12/2/2021.(jl, )
Related: [-]
6 6 30+ pgs order Order Mon 12/06 10:49 AM
ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days of the date of this Order to (1) establish that service was effected on the identified AZ Defendants as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss the identified AZ Defendants, or (3) show cause why the identified AZ Defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 12/2/2021.(jl, )
Related: [-]
Monday, November 22, 2021
5 5 19 pgs order Order Mon 11/22 7:10 AM
ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days as follows (1) establish that service was effected on the identified P&G and PGM defendants as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss the identified P&G and PGM defendants, or (3) show cause why the identified P&G and PGM defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 11/19/2021. (jl, )
Related: [-]
4 4 14 pgs order Order Mon 11/22 6:42 AM
ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days as follows: (1) establish that service was effected on Abbott as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss Abbott, or (3) show cause why Abbott should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 11/19/2021. (jl, )
Related: [-]
3 3 21 pgs order Order Mon 11/22 5:35 AM
ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days as follows: (1) establish that service was effected on the Takeda Defendants as required by Rule4(m) by filing proof of service, (2) voluntarily dismiss the Takeda Defendants, or (3) show cause why the Takeda Defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 11/19/2021.(jl, )
Related: [-]
Wednesday, March 13, 2019
2 2 service Summons Issued Wed 03/13 9:29 AM
SUMMONS ISSUED as to ABBOTT LABORATORIES, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, MERCK & CO. INC. D/B/A MERCK, SHARP & DOHME CORPORATION, NOVARTIS CONSUMER HEALTH, INC., NOVARTIS CORPORATION, NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC., NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., TAKEDA DEVELOPMENT CENTER AMERICAS, INC. F/K/A TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS AMERICA INC., TAKEDA PHARMACEUTICALS USA, INC., THE PROCTER & GAMBLE COMPANY, THE PROCTER & GAMBLE MANUFACTURING COMPANY. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (gh, )
Related: [-]
order Case Management Order Wed 03/13 9:30 AM
For all Case Management Orders[LINK:click here] (gh, )
Related: [-]
mdl MDL Direct File Wed 03/13 9:31 AM
Member Case Direct File on 3/12/19, for MDL 2789 PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) (gh, )
Related: [-]
Tuesday, March 12, 2019
1 1 cmp Complaint Tue 03/12 3:08 PM
COMPLAINT against ABBOTT LABORATORIES, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, MERCK & CO. INC. D/B/A MERCK, SHARP & DOHME CORPORATION, NOVARTIS CONSUMER HEALTH, INC., NOVARTIS CORPORATION, NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC., NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., TAKEDA DEVELOPMENT CENTER AMERICAS, INC. F/K/A TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS AMERICA INC., TAKEDA PHARMACEUTICALS USA, INC., THE PROCTER & GAMBLE COMPANY, THE PROCTER & GAMBLE MANUFACTURING COMPANY ( Filing and Admin fee $ 400 receipt number 0312-9492251) with JURY DEMAND, filed by MATTHEW LOYD.(CALLAHAN, LUKE)
Related: [-]
Att: 1 Civil Cover Sheet